Patient Preferences for Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. Hamad A, Crossnohere N, Ejaz A, Tsung A, et al. Pancreas 2022 Sep 13. pii: 00006676-990000000-00035.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hamad A, Crossnohere N, Ejaz A, Tsung A, et al. Patient Preferences for Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. Pancreas 2022 Sep 13. pii: 00006676-990000000-00035.
PMID: 36099500